Cogent Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,177 | -1,157 | -1,138 | |
EBITDA | -108,680 | -78,830 | -72,058 | -73,795 |
EBIT | -105,744 | -79,471 | -73,215 | -74,933 |
Net Income | -102,492 | -80,930 | -73,529 | -71,986 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -79,916 | -64,351 | -54,673 | -67,058 |
Cash | 312,012 | 125,297 | 127,598 | 126,003 |
Basic Shares | 67,600 | 114,466 | 114,466 | 113,307 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,619 | -4,401 | -3,588 | -5,878 |
EBITDA | -328,744 | -271,588 | -204,542 | -141,961 |
EBIT | -333,363 | -275,939 | -208,130 | -147,839 |
Net Income | -328,937 | -255,859 | -192,410 | -132,643 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -79,798 | |||
Free Cash Flow | -265,998 | -208,364 | -156,420 | -125,501 |
Cash | 312,012 | 98,165 | 53,229 | 139,886 |
Basic Shares | 67,600 | 103,856 | 79,657 | 58,739 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.56 |
2025-09-30 | -$0.50 |
2025-06-30 | -$1.27 |
